{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-139482","form_type":"8-K","ticker":"FDMT","cik":"0001650648","company_name":"4D Molecular Therapeutics, Inc.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.840785+00:00","generated_at":"2026-06-15T09:19:21.299623+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"4D Molecular Therapeutics closes $129.1M public offering of 8.625M shares at $16/share","bullets":["Sold 7.5M firm shares plus 1.125M overallotment shares at $16.00 per share, netting ~$129.1M.","Underwriters include Goldman Sachs, BofA Securities, and Evercore; lock-up restrictions until July 3, 2023.","Offering closed on May 9, 2023; proceeds for general corporate purposes per shelf registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-139482","json":"https://secwatch.observer/filing/0001193125-23-139482.json","markdown":"https://secwatch.observer/filing/0001193125-23-139482.md","text":"https://secwatch.observer/filing/0001193125-23-139482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/0001193125-23-139482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/d611852d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T09:19:21.299623+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}